Compare NICE Ltd (NICE) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NICE Ltd vs TransMedics Group Inc — how do they compare? NICE Ltd trades at $94.34 (market cap $5.91B), while TransMedics Group Inc trades at $73.5 (market cap $2.54B). The key difference: NICE Ltd is far larger — about 2.3× TransMedics Group Inc's market cap. Which is the better fit depends on your goals.
| NICE | TMDX | |
|---|---|---|
Market Cap | $5.91B | $2.54B |
Sector | Technology | Technology |
52-Week High | $170.37 | $150.42 |
52-Week Low | $83.15 | $61.99 |
Enterprise Value | $5.69B | $2.94B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NICE trades at $101.34, up 1.19% today, with a bullish technical signal and strong support near $99. The stock shows solid fundamentals with a P/E of 12.02, net income margin of 17.57%, and consistent earnings beats in recent quarters. Recent news highlights enterprise AI deployments with Banco do Brasil and Sopra Steria, reinforcing growth in customer engagement solutions.
The outlook remains positive with a consensus price target of $123.33, representing 22% upside potential. Risks include competitive pressures in AI software and potential margin compression, but analyst sentiment is strongly bullish with no sell ratings. Institutional interest is supported by robust cash flow generation and strategic AI expansions.
TransMedics (TMDX) is trading at $73.47, down 0.69% on the day, amid a mixed technical and fundamental backdrop. The stock shows neutral technical signals with support near $72 and resistance at $75, while fundamentals are strong with a trailing P/E of 16.81 and robust profitability metrics like a 27.04% net income margin. Recent earnings saw a Q1 2026 miss but beats in prior quarters, and the company is expanding in Europe through strategic investments.
The outlook is cautiously optimistic with a consensus price target of $108.71 implying significant upside, supported by 75% analyst buy ratings. Key risks include margin pressure from expansion costs and competitive threats, but the company's organ transplant logistics network offers a durable competitive advantage for long-term growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NICE Ltd
NICE Ltd. is a global leader in both enterprise software and cloud computing, specializing in customer experience and financial crime prevention solutions. The company's platform utilizes advanced analytics, AI, and automation to help organizations enhance customer interactions, ensure compliance, and combat fraud. NICE serves a diverse client base, including contact centers, financial institutions, and government agencies, by optimizing operations and improving service quality.
Read more on NICE →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
